Kausik Umanath

A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy

David C. Wheeler, Robert D. Toto, Bergur V. Stefánsson et al. · Kidney International · 2021 · 369 citations · Full text

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics

David C. Wheeler, Bergur V. Stefánsson, Oleksandr Bilchenko et al. · Nephrology Dialysis Transplantation · 2020 · 180 citations · Full text

Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT)

Michael V. Rocco, Kaycee M. Sink, Laura Lovato et al. · American Journal of Kidney Diseases · 2017 · 125 citations · Full text

Hypertension, Renal Function, Antihypertensive Therapy +7

Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD

Kausik Umanath, Diana Jalal, Barbara Greco et al. · Journal of the American Society of Nephrology · 2015 · 120 citations · Full text

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs et al. · European Heart Journal · 2021 · 118 citations · Full text